These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24277340)
1. A patient with hypertrophic cardiomyopathy undergoing non-cardiac surgery. Elias TC; Partridge JS; McCorkell SA; Dhesi JK BMJ; 2013 Nov; 347():f6910. PubMed ID: 24277340 [No Abstract] [Full Text] [Related]
2. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Slade AK; Camm AJ Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163 [TBL] [Abstract][Full Text] [Related]
8. [Sudden death in hypertrophic myocardiopathy]. Cardim N; Longo S; Gouveia D; Lousada N; Ferreira T; Pereira AT; Correia JM Rev Port Cardiol; 1995 Sep; 14(9):655-9. PubMed ID: 7576766 [TBL] [Abstract][Full Text] [Related]
9. Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery. Dhillon A; Khanna A; Randhawa MS; Cywinski J; Saager L; Thamilarasan M; Lever HM; Desai MY Heart; 2016 Oct; 102(20):1627-32. PubMed ID: 27288277 [TBL] [Abstract][Full Text] [Related]
10. Device therapy in hypertrophic cardiomyopathy. Beadle R; Williams L Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1767-75. PubMed ID: 21108558 [TBL] [Abstract][Full Text] [Related]
11. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. McKenna WJ; Behr ER Heart; 2002 Feb; 87(2):169-76. PubMed ID: 11796562 [No Abstract] [Full Text] [Related]
12. [Sudden death and obstructive hypertrophic cardiomyopathy]. Baille N Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):155-60. PubMed ID: 3890678 [TBL] [Abstract][Full Text] [Related]
13. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects]. Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348 [TBL] [Abstract][Full Text] [Related]
14. [Arrhythmias in cardiomyopathy and specific myocardial diseases]. Yamaoki K; Yazaki Y Nihon Rinsho; 1991 Nov; 49(11):2622-9. PubMed ID: 1770599 [No Abstract] [Full Text] [Related]
15. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy. Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087 [TBL] [Abstract][Full Text] [Related]
16. Sudden cardiac death in hypertrophic cardiomyopathy. Maron BJ; Fananapazir L Circulation; 1992 Jan; 85(1 Suppl):I57-63. PubMed ID: 1728506 [TBL] [Abstract][Full Text] [Related]
17. [Asymptomatic hypertrophic myocardiopathy. The arguments in favor of its treatment]. Penas Lado M; Castro Beiras A Rev Esp Cardiol; 1995 Aug; 48(8):522-7. PubMed ID: 7644805 [No Abstract] [Full Text] [Related]
18. Hypertrophic cardiomyopathy: management issues in the new millennium. Thaman R; Firoozi S; Hamid MS; McKenna WJ Curr Cardiol Rep; 2002 May; 4(3):226-32. PubMed ID: 11960592 [TBL] [Abstract][Full Text] [Related]
19. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?]. Grobéty M; Schlaepfer J; Kappenberger L; Fromer M Schweiz Med Wochenschr; 1997 Apr; 127(15):623-30. PubMed ID: 9198888 [TBL] [Abstract][Full Text] [Related]
20. Sudden cardiac death in young athletes. Leikin SM; Pierce A; Nelson M Dis Mon; 2013 Mar; 59(3):97-101. PubMed ID: 23410670 [No Abstract] [Full Text] [Related] [Next] [New Search]